Inquiry Basket
Loading ......
Filter By Product Search for
TAP1
TAP1 Full Name
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP)
TAP1 Introduction
TAP1 (transporter associated with antigen processing 1) is a key ATP-binding cassette (ABC) transporter within the ABCB subfamily that plays a central role in antigen processing and immune surveillance. Functionally, TAP1 forms a heterodimer with TAP2 in the endoplasmic reticulum membrane, where it transports cytosolic peptide fragments into the ER lumen for loading onto MHC class I molecules. This peptide "import checkpoint" is essential for generating immunogenic peptide–MHC complexes that allow CD8+ T cells to recognize infected or transformed cells. When TAP1 is defective or downregulated, antigen presentation becomes inefficient, creating a major immune "blind spot" that is frequently exploited in chronic infections and cancer immune evasion. Large-scale reviews on ABC transporters in disease contexts have also emphasized TAP1 as part of a broader network linking transporter dysfunction to systemic inflammatory and hepatic disorders, highlighting its importance beyond classical immunology.
From a disease perspective, TAP1 has emerged as a clinically meaningful immuno-oncology and inflammation-related biomarker, particularly in solid tumors. Multiple studies indicate that TAP1 expression is often elevated in tumors and closely associated with immune activation signatures, including T-cell infiltration and antigen presentation pathway enrichment. Importantly, higher TAP1 levels have been linked to improved immune recognition and can correlate with patient outcomes and response to immunotherapy, suggesting its potential utility in patient stratification for checkpoint blockade therapies. At the same time, TAP1 is not uniformly beneficial, as tumor cells can hijack its regulatory network to adapt immune visibility, creating a context-dependent role in tumor progression and immune editing.
More recent mechanistic insights reveal that TAP1 activity is not only transcriptionally regulated but also strongly influenced by post-translational modifications that directly affect immune escape. A recent study demonstrated that O-GlcNAcylation of TAP1 disrupts its interaction with MHC class I molecules, leading to impaired antigen presentation and enhanced immune evasion in bladder cancer models. This modification further promotes abnormal trafficking and degradation of MHC I complexes, ultimately weakening CD8+ T cell cytotoxic responses and reshaping the tumor immune microenvironment. Together, these findings position TAP1 as a central "immune gatekeeper" whose dysfunction connects metabolic signaling, antigen processing failure, and therapeutic resistance across multiple disease settings.
Alternate Names for TAP1
TAP1; transporter 1, ATP-binding cassette, sub-family B (MDR/TAP); APT1; PSF1; ABC17; ABCB2; PSF-1; RING4; TAP1N; D6S114E
Loading ......
